for people living with dementia
play

FOR PEOPLE LIVING WITH DEMENTIA Ellen Tambor,MA On Behalf of the - PowerPoint PPT Presentation

National Institute on Aging (NIA) IMbedded Pragmatic Alzheimers Disease (AD) and AD-Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory (NIA U54AG063546) STAKEHOLDER ENGAGEMENT IN ePCTs FOR PEOPLE LIVING WITH DEMENTIA Ellen


  1. National Institute on Aging (NIA) IMbedded Pragmatic Alzheimer’s Disease (AD) and AD-Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory (NIA U54AG063546) STAKEHOLDER ENGAGEMENT IN ePCTs FOR PEOPLE LIVING WITH DEMENTIA Ellen Tambor,MA On Behalf of the Stakeholder Engagement Team

  2. Housekeeping • All participants will be muted • Enter all questions in the Zoom chat box and send to everyone • Moderator will review questions from chat box and ask them at the end • Want to continue the discussion? Look for the associated podcast released about 2 weeks after Grand Rounds. • Visit impactcollaboratory.org • Follow us on Twitter: @IMPACTcollab1

  3. IMPACT Stakeholder Engagement Team (SET) Leader Administrative Core Liaisons • Gary Epstein-Lubow, MD • Susan Mitchell, MD, MPH • Jill Harrison, PhD Associate Team Leader • Katie Maslow, MSW Core Support • Laurie Herndon, MSN Executive Committee Members • Louise Phillips, MD • Ellen Tambor, MA

  4. Agenda • Definitions and Rationale for Stakeholder Engagement in Research • Importance of Engagement in ePCTs • Special Considerations for Engagement in ePCTs for AD/ADRD • Role of Stakeholder Engagement in the IMPACT Collaboratory

  5. Stakeholder Engagement Who to Engage Definitions* Patients • Includes advocates, family members, and Stakeholder: Responsible for or affected by health- and family caregivers healthcare-related decisions Clinicians • Clinical experts, clinician leaders, front-line clinicians (physicians, nurses and other Engagement: Bi-directional direct care staff) relationship between the Other Stakeholders stakeholder and researcher • Administrators, payors, research funders, etc. *Concannon TW, Meissner P, Grunbaum JA, et al. A new taxonomy for stakeholder engagement in patient-centered outcomes research. J Gen Intern Med 2012;27:985 – 991.

  6. Rationale for Engagement Right of citizens to have a voice in the use of public funds Moral/Ethical Arguments Right of individuals to be involved in “Nothing shaping research that pertains to them about us, without us” Improving the quality, relevance, and usefulness of clinical research Pragmatic Arguments Increasing transparency, credibility, and trust in the clinical research enterprise

  7. Importance of Engagement in ePCTs • Pragmatic Clinical Trial (PCT) • “Designed for the primary purpose of PCTs must answer questions that are informing decision-makers important to patients, clinicians, and regarding the comparative balance of other healthcare decision makers benefits, burdens and risks of a biomedical or behavioral health intervention at the individual or population level” * ePCTs must be feasible to conduct in complex healthcare delivery • Embedded PCT (ePCT) settings where patient care is the • Pragmatic randomized clinical trials top priority embedded in routine health care * Califf RM and Sugarman J. Exploring the ethical and regulatory issues in pragmatic clinical trials. Clin Trials. 2015;12(5):436-41.

  8. Engagement Throughout the ePCT Life Cycle Fraser J, Moloney R, Tambor E, Tuzzio L. Building Partnerships to Ensure a Successful Trial: Stakeholder Engagement Throughout the PCT Life Cycle. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Health Care Systems Research Collaboratory. Available at: https://rethinkingclinicaltrials.org/chapters/engaging- stakeholders/stakeholder-engagement-throughout-the-pct-life-cycle/.

  9. Stakeholder Engagement in ePCTs for AD/ADRD Special Considerations for Engaging: • People living with dementia (PLWD) and their family caregivers • Healthcare system stakeholders

  10. Special Considerations for Engaging PLWD Matching Accommodating Engagement Engaging Capacity Heterogeneity Approaches Caregivers Range in Cognitive Caregiver Flexibility disease severity symptoms burden Preparation Strengths and Race/ethnicity and support preferences Caregivers as proxy respondents Familiarity with Socioeconomic Meeting research status logistics Caregivers as Symptom independent Timelines Geography progression stakeholders

  11. Special Considerations for Engaging Healthcare Stakeholders Diverse Professional Roles Diverse Care Settings • Physician • Hospital • Nursing Home • Nurse • Adult Day Center • Medical/Nursing Assistant • In-Home Care • Physical Therapist • Occupational Therapist Clinician and Other Care Provider Burden • Complex care needs of PLWD • Shortage of dementia-capable work force • Staff turnover • Nursing home crises (COVID-19)

  12. Stakeholder Engagement in the IMPACT Collaboratory

  13. Stakeholder Engagement in the IMPACT Collaboratory

  14. Stakeholder Advisory Committee Role: Advise the IMPACT Collaboratory about stakeholder engagement activities, strategies to assist investigators with stakeholder engagement, and priority topics for the development of guidance materials. Membership: • Leading Age • People living with dementia (2) • AARP • Alzheimer’s Association • AMDA: Society for Post-Acute and Long-Term Care • National Alliance for Caregiving Medicine • LEAD Coalition • American Geriatrics Society • Association for Frontotemporal Degeneration • Centers for Medicare and Medicaid Services • Lewy Body Dementia Association • Veterans Administration

  15. Stakeholder Engagement in the IMPACT Collaboratory

  16. Lived Experience Panel Collaboration between IMPACT Collaboratory (PCRO and SET) and the Alzheimer’s Association (AA) Panel Composition: Role: ● 4 - Individuals living with a diagnosis of early ● Reflect on outcomes and stage Alzheimer’s, Mild Cognitive Impairment relevance of pilot studies (MCI) or other dementia ● Identify high priority outcomes ● 4 - Care partners/caregivers of an individual and gaps living with dementia ● Review written documents ● 4 - Caregivers/family members who can represent the perspective of one or more individuals living in the middle or late stage

  17. Stakeholder Engagement in the IMPACT Collaboratory

  18. Topic Prioritization 2017 National Research Summit on Care, Services, and Supports for Persons with Dementia and Their Caregivers • Persons Living with Dementia Stakeholder Group “Top 6 Outcomes that Matter” 1. Psychosocial care practices and behavioral strategies to address problematic symptoms 2. Person-centered approaches to assessment and care planning 3. Tailored resources and models of coordinated care Implications for use of the term “cognitive impairment” or “cognitive disorder” instead of 4. “dementia” 5. Implications on advocacy, stigma and reported prevalence rates as a result of consolidating disease names of all memory disorders 6. Implications of financial burden on diagnosis, treatment, and research participation Frank L, Shubeck E, Schicker M, et al. Contributions of persons living with dementia to scientific research meetings. Results from the National Research Summit on Care, Services, and Supports for persons with dementia and their caregivers. Am J of Geriatric Psychiatry. 2020;28(4):421-430.

  19. Stakeholder Engagement in the IMPACT Collaboratory IMPACT 101

  20. Stakeholder Engagement in the IMPACT Collaboratory

  21. Stakeholder Engagement in the IMPACT Collaboratory

  22. RAPT Model Readiness Assessment for Pragmatic Trials Baier, Jutkowitz, Mitchell, McCreedy and Mor, 2019

  23. RAPT Model Readiness Assessment for Pragmatic Trials PLWD Family Members Caregivers Providers Direct Care Staff Administrators Payors Baier, Jutkowitz, Mitchell, McCreedy and Mor, 2019

  24. RAPT Model Readiness Assessment for Pragmatic Trials PLWD Family Members Caregivers Providers Direct Care Staff Administrators Payors Baier, Jutkowitz, Mitchell, McCreedy and Mor, 2019

  25. RAPT Model Readiness Assessment for Pragmatic Trials PLWD Family Members Caregivers Providers Direct Care Staff Administrators Payors Baier, Jutkowitz, Mitchell, McCreedy and Mor, 2019

  26. RAPT Model Readiness Assessment for Pragmatic Trials PLWD Family Members Caregivers Providers Direct Care Staff Administrators Payors Baier, Jutkowitz, Mitchell, McCreedy and Mor, 2019

  27. RAPT Model Readiness Assessment for Pragmatic Trials PLWD Family Members Caregivers Providers Direct Care Staff Administrators Payors Baier, Jutkowitz, Mitchell, McCreedy and Mor, 2019

  28. RAPT Model Readiness Assessment for Pragmatic Trials PLWD Family Members Caregivers Providers Direct Care Staff Administrators Payors Baier, Jutkowitz, Mitchell, McCreedy and Mor, 2019

  29. Stakeholder Engagement in the IMPACT Collaboratory

  30. Questions?

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend